Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease

Rizwan Masud1, Khader Shameer1, Aparna Dhar1

  • 1Division of Cardiovascular Diseases, Mayo Clinic, Rochester MN 55905, USA.

Insights

Peripheral arterial disease (PAD) involves altered gene expression in monocytes. Upregulated genes relate to inflammation and clotting, while downregulated genes affect gene regulation, offering insights into PAD.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Genomics

Background:

  • Peripheral arterial disease (PAD) is a common complication of atherosclerosis, affecting leg arteries.
  • Circulating monocytes can indicate vascular pathology in PAD patients.
  • Gene expression analysis of peripheral blood mononuclear cells (PBMC) can identify disease-specific molecular changes.

Purpose of the Study:

  • To identify differentially regulated genes in PBMCs from PAD patients compared to controls.
  • To understand the molecular mechanisms underlying PAD pathophysiology through gene expression profiling.

Main Methods:

  • Gene expression analysis using microarray (Affymetrix HG-U133 plus 2.0).
  • Comparison of PBMCs from 19 PAD patients (ABI ≤0.9) and 18 controls (ABI > 1.0).
  • Bioinformatic analysis including enrichment and network analysis (GO, KEGG, Reactome, IPA).

Main Results:

  • Identified 87 differentially expressed genes in PAD patients (40 upregulated, 47 downregulated).
  • Upregulated genes are involved in immune response, inflammation, apoptosis, and platelet activation.
  • Downregulated genes include zinc finger family genes crucial for transcriptional regulation.

Conclusions:

  • Gene expression profiling reveals key molecular pathways in PAD pathophysiology.
  • Upregulated genes highlight inflammatory and thrombotic processes.
  • Downregulated genes suggest altered transcriptional control in PAD.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...